A transcriptional enhancer in the G allele of rs554219 increases the risk of breast cancer by reducing the binding of ELK4 transcription factor and correlates with low cyclin D1 levels in breast cancer tissues [116]. The gene discussed is ELK4; the disease is breast carcinoma.